186 related articles for article (PubMed ID: 6196244)
1. Circulating IgG antibody to protamine in patients treated with protamine-insulins.
Kurtz AB; Gray RS; Markanday S; Nabarro JD
Diabetologia; 1983 Oct; 25(4):322-4. PubMed ID: 6196244
[TBL] [Abstract][Full Text] [Related]
2. Protamine antibody production in diabetic subjects treated with NPH insulin.
Ellerhorst JA; Comstock JP; Nell LJ
Am J Med Sci; 1990 May; 299(5):298-301. PubMed ID: 2337121
[TBL] [Abstract][Full Text] [Related]
3. Frequency and specificity of protamine antibodies in diabetic and control subjects.
Nell LJ; Thomas JW
Diabetes; 1988 Feb; 37(2):172-6. PubMed ID: 3292313
[TBL] [Abstract][Full Text] [Related]
4. [ELISA detection of protamine antibodies].
Junker M; Hobler H; Federlin K
Immun Infekt; 1985 Apr; 13(2):80-2. PubMed ID: 3888823
[TBL] [Abstract][Full Text] [Related]
5. Insulin antibodies induced by bovine insulin therapy.
Reeves WG; Kelly U
Clin Exp Immunol; 1982 Oct; 50(1):163-70. PubMed ID: 6756728
[TBL] [Abstract][Full Text] [Related]
6. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
7. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
[TBL] [Abstract][Full Text] [Related]
8. Bovine and human NPH insulins as T cell immunogens.
Gregory R; Tattersall RB
Diabetes Res Clin Pract; 1993 May; 20(2):139-46. PubMed ID: 8375267
[TBL] [Abstract][Full Text] [Related]
9. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
Dorchy H; Duchateau J; Bosson D; D'Hooge D
Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
[TBL] [Abstract][Full Text] [Related]
10. Protamine insulin mixtures in the treatment of diabetes mellitus.
COLWELL AR
N Y State J Med; 1947 May; 47(10):1103-10. PubMed ID: 20239260
[No Abstract] [Full Text] [Related]
11. Intermediate-acting insulin preparations: NPH and lente.
Deckert T
Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
[TBL] [Abstract][Full Text] [Related]
12. Protamine-containing insulin but not analog insulin and duration of insulin use are risk factors for the production of insulin autoantibodies in insulin-treated patients with diabetes mellitus.
Nishimura H; Iizuka K; Takeda J
Endocr J; 2014; 61(6):635-40. PubMed ID: 24681758
[TBL] [Abstract][Full Text] [Related]
13. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.
Weiss ME; Nyhan D; Peng ZK; Horrow JC; Lowenstein E; Hirshman C; Adkinson NF
N Engl J Med; 1989 Apr; 320(14):886-92. PubMed ID: 2648147
[TBL] [Abstract][Full Text] [Related]
14. U-500 insulin in the treatment of antibody-mediated insulin resistance.
Nathan DM; Axelrod L; Flier JS; Carr DB
Ann Intern Med; 1981 May; 94(5):653-6. PubMed ID: 7015948
[TBL] [Abstract][Full Text] [Related]
15. Serial immunological investigations in a patient who had a life-threatening reaction to intravenous protamine.
Weiss ME; Chatham F; Kagey-Sobotka A; Adkinson NF
Clin Exp Allergy; 1990 Nov; 20(6):713-20. PubMed ID: 1707334
[TBL] [Abstract][Full Text] [Related]
16. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
[TBL] [Abstract][Full Text] [Related]
17. [INSULIN THERAPY OF DIABETES MELLITUS].
KATSUKI S; HIRATA Y
Naika; 1964 Apr; 13():709-15. PubMed ID: 14151351
[No Abstract] [Full Text] [Related]
18. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
Yue DK; Turtle JR
Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of highly purified pig-insulin preparations.
Deckert T; Andersen OO; Poulsen JE
Diabetologia; 1974 Dec; 10(6):703-8. PubMed ID: 4474966
[No Abstract] [Full Text] [Related]
20. [Immunogenicity of MC Lente Novo insulin].
Rogala H; Lawecki J; Czyzyk A
Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
